Surgepays Stock Performance
| SURG Stock | USD 2.01 0.42 17.28% |
The entity has a beta of 2.72, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Surgepays will likely underperform. At this point, Surgepays has a negative expected return of -0.0942%. Please make sure to validate Surgepays' maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and market facilitation index , to decide if Surgepays performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Surgepays has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Surgepays is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Actual Historical Performance (%)
Five Day Return (17.15) | Year To Date Return 12.64 | Ten Year Return (96.63) | All Time Return (96.63) |
Last Split Factor 1:50 | Last Split Date 2021-11-02 |
1 | Is SurgePays Inc. stock poised for growth - Price Action Verified High Yield Trade Plans - newser.com | 09/29/2025 |
2 | How institutional ownership impacts SurgePays Inc. stock - July 2025 Decliners Expert Approved Momentum Trade Ideas - newser.com | 10/21/2025 |
3 | Will SurgePays Inc. stock rally after Fed decisions - Market Growth Summary AI Driven Stock Price Forecasts - newser.com | 10/28/2025 |
4 | SurgePays Unlocks New Revenue Channel with Launch of Growth Marketing Data Partnerships Division | 10/30/2025 |
5 | SurgePays, Inc. Short Interest Down 42.1 percent in October | 11/03/2025 |
6 | Will SurgePays Inc. stock sustain high P E ratios - July 2025 Pullbacks Low Drawdown Momentum Ideas - newser.com | 11/05/2025 |
7 | SurgePays Revenue for the Third Quarter 2025 Increases 292 percent Year-Over-Year and 62 percent Sequentially | 11/12/2025 |
8 | SurgePays Unveils ProgramBenefits.com as Next Phase in Data Monetization Strategy | 11/13/2025 |
9 | SurgePays, Inc. Q3 2025 Earnings Call Transcript | 11/14/2025 |
| Begin Period Cash Flow | 14.6 M | |
| Total Cashflows From Investing Activities | -3 M |
Surgepays | Build AI portfolio with Surgepays Stock |
Surgepays Relative Risk vs. Return Landscape
If you would invest 227.00 in Surgepays on August 18, 2025 and sell it today you would lose (26.00) from holding Surgepays or give up 11.45% of portfolio value over 90 days. Surgepays is currently does not generate positive expected returns and assumes 4.2489% risk (volatility on return distribution) over the 90 days horizon. In different words, 38% of stocks are less volatile than Surgepays, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Surgepays Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Surgepays' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Surgepays, and traders can use it to determine the average amount a Surgepays' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0222
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SURG |
Estimated Market Risk
| 4.25 actual daily | 38 62% of assets are more volatile |
Expected Return
| -0.09 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Surgepays is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Surgepays by adding Surgepays to a well-diversified portfolio.
Surgepays Fundamentals Growth
Surgepays Stock prices reflect investors' perceptions of the future prospects and financial health of Surgepays, and Surgepays fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Surgepays Stock performance.
| Return On Equity | -2.11 | ||||
| Return On Asset | -0.82 | ||||
| Profit Margin | (1.34) % | ||||
| Operating Margin | (0.59) % | ||||
| Current Valuation | 51.95 M | ||||
| Shares Outstanding | 21.04 M | ||||
| Price To Earning | 11.14 X | ||||
| Price To Book | 445.31 X | ||||
| Price To Sales | 1.16 X | ||||
| Revenue | 60.88 M | ||||
| Gross Profit | (24.66 M) | ||||
| EBITDA | (41.22 M) | ||||
| Net Income | (45.94 M) | ||||
| Cash And Equivalents | 8.7 M | ||||
| Cash Per Share | 0.70 X | ||||
| Total Debt | 4.59 M | ||||
| Debt To Equity | 6.32 % | ||||
| Current Ratio | 1.07 X | ||||
| Book Value Per Share | 0.76 X | ||||
| Cash Flow From Operations | (21.31 M) | ||||
| Earnings Per Share | (2.13) X | ||||
| Market Capitalization | 42.29 M | ||||
| Total Asset | 23.98 M | ||||
| Retained Earnings | (60.92 M) | ||||
| Working Capital | 11.81 M | ||||
| Current Asset | 46.28 M | ||||
| Current Liabilities | 9.69 M | ||||
About Surgepays Performance
By analyzing Surgepays' fundamental ratios, stakeholders can gain valuable insights into Surgepays' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Surgepays has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Surgepays has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 8.65 | 9.08 | |
| Return On Tangible Assets | (2.38) | (2.50) | |
| Return On Capital Employed | (2.33) | (2.22) | |
| Return On Assets | (1.91) | (2.00) | |
| Return On Equity | (2.99) | (2.84) |
Things to note about Surgepays performance evaluation
Checking the ongoing alerts about Surgepays for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Surgepays help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Surgepays generated a negative expected return over the last 90 days | |
| Surgepays has high historical volatility and very poor performance | |
| Surgepays has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 60.88 M. Net Loss for the year was (45.94 M) with loss before overhead, payroll, taxes, and interest of (24.66 M). | |
| Surgepays currently holds about 8.7 M in cash with (21.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.7. | |
| Surgepays has a poor financial position based on the latest SEC disclosures | |
| Roughly 37.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from insidermonkey.com: SurgePays, Inc. Q3 2025 Earnings Call Transcript |
- Analyzing Surgepays' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Surgepays' stock is overvalued or undervalued compared to its peers.
- Examining Surgepays' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Surgepays' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Surgepays' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Surgepays' stock. These opinions can provide insight into Surgepays' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Surgepays Stock analysis
When running Surgepays' price analysis, check to measure Surgepays' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgepays is operating at the current time. Most of Surgepays' value examination focuses on studying past and present price action to predict the probability of Surgepays' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgepays' price. Additionally, you may evaluate how the addition of Surgepays to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |